New Insights Into Refractory Chronic Cough and Unexplained Chronic Cough: A 6-Year Ambispective Cohort Study.

IF 4.1 2区 医学 Q2 ALLERGY Allergy, Asthma & Immunology Research Pub Date : 2023-11-01 DOI:10.4168/aair.2023.15.6.795
Mengru Zhang, Alyn H Morice, Fengli Si, Li Zhang, Qiang Chen, Shengyuan Wang, Yiqing Zhu, Xianghuai Xu, Li Yu, Zhongmin Qiu
{"title":"New Insights Into Refractory Chronic Cough and Unexplained Chronic Cough: A 6-Year Ambispective Cohort Study.","authors":"Mengru Zhang, Alyn H Morice, Fengli Si, Li Zhang, Qiang Chen, Shengyuan Wang, Yiqing Zhu, Xianghuai Xu, Li Yu, Zhongmin Qiu","doi":"10.4168/aair.2023.15.6.795","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Only limited studies have depicted the unique features and management of refractory chronic cough (RCC) and unexplained chronic cough (UCC). These led to the initiation of this study, which reported the demographic characteristics, manifestations, and long-term outcomes on a large series of consecutive RCC/UCC patients, providing a guideline-led real-world clinical experience.</p><p><strong>Methods: </strong>Retrospective baseline information was obtained from Clinical Research Database (January 2016 to May 2021). At least 6 months after the last clinic visit, included subjects were prospectively followed up.</p><p><strong>Results: </strong>Three hundred and sixty-nine RCC and UCC patients (199 females, 53.9%) were analyzed. The median cough duration was 24.0 (12.0-72.0) months. Laryngeal symptoms were reported in 95.9% of the patients. The common triggers for coughing were talking (74.9%), pungent odors (47.3%), eating (45.5%), and cold air (42.8%). RCC was considered in 38.2%, and the remainder of 228 patients had UCC, with an equal sex distribution (<i>P</i> = 0.66). Among the 141 RCCs, 90.8% (128) had refractory reflux cough, which was more responsive to current treatments (<i>P</i> < 0.01). Although most features and test results between RCC and UCC were similar, UCC was more commonly inappropriately treated (<i>P</i> < 0.01). Nineteen (7.7-41.1) months after the final clinic visit, 31.2% still coughed persistently, while 68.8% reported cough improvement or remission. RCC reported more favorable treatment outcomes (including cough improvement, control, and spontaneous remission) than UCC (<i>P</i> < 0.01). Coughs with long duration before the initial cough clinic visit (<i>P</i> < 0.01), frequent urinary incontinence (<i>P</i> < 0.01), and being sensitive to \"talking\" (<i>P</i> < 0.01) or \"cold air\" (<i>P</i> < 0.01) were less likely to be solved.</p><p><strong>Conclusions: </strong>The current treatments only improve cough symptoms in two-thirds of patients. Clinical indicators for treatment failure were those coughing for long duration and being sensitive to \"talking\" or \"cold air.\"</p>","PeriodicalId":7547,"journal":{"name":"Allergy, Asthma & Immunology Research","volume":"15 6","pages":"795-811"},"PeriodicalIF":4.1000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643855/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergy, Asthma & Immunology Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4168/aair.2023.15.6.795","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Only limited studies have depicted the unique features and management of refractory chronic cough (RCC) and unexplained chronic cough (UCC). These led to the initiation of this study, which reported the demographic characteristics, manifestations, and long-term outcomes on a large series of consecutive RCC/UCC patients, providing a guideline-led real-world clinical experience.

Methods: Retrospective baseline information was obtained from Clinical Research Database (January 2016 to May 2021). At least 6 months after the last clinic visit, included subjects were prospectively followed up.

Results: Three hundred and sixty-nine RCC and UCC patients (199 females, 53.9%) were analyzed. The median cough duration was 24.0 (12.0-72.0) months. Laryngeal symptoms were reported in 95.9% of the patients. The common triggers for coughing were talking (74.9%), pungent odors (47.3%), eating (45.5%), and cold air (42.8%). RCC was considered in 38.2%, and the remainder of 228 patients had UCC, with an equal sex distribution (P = 0.66). Among the 141 RCCs, 90.8% (128) had refractory reflux cough, which was more responsive to current treatments (P < 0.01). Although most features and test results between RCC and UCC were similar, UCC was more commonly inappropriately treated (P < 0.01). Nineteen (7.7-41.1) months after the final clinic visit, 31.2% still coughed persistently, while 68.8% reported cough improvement or remission. RCC reported more favorable treatment outcomes (including cough improvement, control, and spontaneous remission) than UCC (P < 0.01). Coughs with long duration before the initial cough clinic visit (P < 0.01), frequent urinary incontinence (P < 0.01), and being sensitive to "talking" (P < 0.01) or "cold air" (P < 0.01) were less likely to be solved.

Conclusions: The current treatments only improve cough symptoms in two-thirds of patients. Clinical indicators for treatment failure were those coughing for long duration and being sensitive to "talking" or "cold air."

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
难治性慢性咳嗽和不明原因慢性咳嗽的新认识:一项为期6年的双视角队列研究。
目的:只有有限的研究描述了难治性慢性咳嗽(RCC)和不明原因慢性咳嗽(UCC)的独特特征和治疗方法。这导致了本研究的启动,该研究报告了大量连续RCC/UCC患者的人口学特征、表现和长期结果,提供了以指南为主导的现实世界临床经验。方法:从临床研究数据库(2016年1月至2021年5月)获取回顾性基线信息。在最后一次门诊就诊后至少6个月,对纳入的受试者进行前瞻性随访。结果:分析了369例RCC和UCC患者,其中女性199例,占53.9%。咳嗽持续时间中位数为24.0(12.0 ~ 72.0)个月。95.9%的患者出现喉部症状。咳嗽的常见诱因为说话(74.9%)、刺鼻气味(47.3%)、进食(45.5%)和冷空气(42.8%)。38.2%的患者考虑为RCC,其余228例患者考虑为UCC,性别分布相等(P = 0.66)。141例rcc中,90.8%(128例)出现难治性反流性咳嗽,对目前的治疗反应较好(P < 0.01)。尽管RCC与UCC的大部分特征和检查结果相似,但UCC的不当治疗更为常见(P < 0.01)。最后一次就诊19个月(7.7 ~ 41.1)后,31.2%的患者仍持续咳嗽,68.8%的患者咳嗽改善或缓解。与UCC相比,RCC报告了更有利的治疗结果(包括咳嗽改善、控制和自发缓解)(P < 0.01)。咳嗽就诊前咳嗽时间过长(P < 0.01)、频繁尿失禁(P < 0.01)、对“说话”敏感(P < 0.01)、对“冷空气”敏感(P < 0.01)等症状解决的可能性较低。结论:目前的治疗方法只能改善三分之二患者的咳嗽症状。治疗失败的临床指标为咳嗽持续时间长,对“说话”或“冷空气”敏感。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.10
自引率
6.80%
发文量
53
审稿时长
>12 weeks
期刊介绍: The journal features cutting-edge original research, brief communications, and state-of-the-art reviews in the specialties of allergy, asthma, and immunology, including clinical and experimental studies and instructive case reports. Contemporary reviews summarize information on topics for researchers and physicians in the fields of allergy and immunology. As of January 2017, AAIR do not accept case reports. However, if it is a clinically important case, authors can submit it in the form of letter to the Editor. Editorials and letters to the Editor explore controversial issues and encourage further discussion among physicians dealing with allergy, immunology, pediatric respirology, and related medical fields. AAIR also features topics in practice and management and recent advances in equipment and techniques for clinicians concerned with clinical manifestations of allergies and pediatric respiratory diseases.
期刊最新文献
Involvement of the Constitutive Photomorphogenesis 9 Signalosome Subunit 5 With Programmed Cell Death Protein 1 Ligand in Asthma. Neutrophil Extracellular Traps as a Biomarker in Refractory Non-Type 2 CRSwNP. Oral Administration of Lactococcus lactis Expressing Mite and Cockroach Major Allergens Alleviates Progression of Atopic March in a Mouse Model. Skin Lipid Barrier: Structure, Function and Metabolism. Treatment With Upadacitinib in Refractory Prurigo Nodularis: A Prospective Cohort Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1